住院复治涂阳肺结核患者的治疗状况调查  

Investigation on the Treatment of Hospitalized Re-treatment Smear Positive TB Patients

作　　者：王琳[1] 翁丽珍[1] 齐巧芳[1] 叶哲香[1] 

机构地区：[1]福建医科大学福州肺科医院,福州350008

出　　处：《海峡预防医学杂志》2007年第5期20-22,共3页Strait Journal of Preventive Medicine

摘　　要：[目的]掌握复治涂阳肺结核患者治疗状况，采取更有效的管理对策。[方法]对2006年1～9月住院的复治涂阳肺结核患者行问卷调查。[结果]本组患者特征：①无收入或低收入者占79．5％，自费治疗者占79．5％；②60．2％患者感就医不便；③85．5％疗程中医生未随访，43．9％曾中断用药，25．9％用药不足1疗程；④27．1％未接受过结核病健康知识教育；⑤69．6％耐异烟肼，61．7％耐利福平，二者都耐者占47．8％。[结论]对初治涂阳肺结核一定要规范治疗，同时行耐药监测；普及对病人的健康教育，及时采取防治措施，尽可能减少复治涂阳病例发生。[Objective] To investigate the of the smear-positive re-treatment pulmonary tuberculosis （TB） patients for the disease control and prevention. [Methods] All hospitalized from Jan, to Sep. in 2006 TB patients with smear-positive re-treatment were investigated by using questionnaire. [Results] The characteristics of this group patients were as follows： ①79.5 % patients was in ,poor families （lower annual average income even no income）. The hospitalized fare of 79.5% patients was at their own expense. ② 60. 2% felt not so convenient to the local hospital. ③ 85.5% patients did not get doctor＇s follow-up. 43.9% patients discontinued medication. 25.9 % did not complete one course of chemotherapy. ④27.1% patients did not get TB health education. ⑤ The resistance rates to isonicotinyl （INH） was 69.6%, 61.7% to rifampin （RFP）, 47.8% to both. [Conclusions] New smear positive TB patients should get standard treatment, and drug resistance surveillance should be strengthened. The health education for TB patients should be popularized. TB control and prevention measure should be carried out for reducing the occurrence of re-treatment TB patients.

关 键 词：肺结核 疾病控制 住院 复治 

分 类 号：R521[医药卫生—内科学]